Nucleic Acid Therapeutics

Journal Metrics
(Based on the publications from the last 4 years)
(from 2022-08-01 to roughly 2026-08-01)
Number of papers138
H4-Index18
TQCC11
Average citations10.326
Median citations4
Impact Factor4.500 (based on Web of Science 2025)

(API-Link)

Categories & Ranks
Metric:
(Based on the publications from the last 4 years)
Most cited by this journal
(Based on citations to the other journals in the most recent 30 papers in this journal, at least if metadata about citations were available; last updated 2025-02-09)
Impactful Papers
(Based on publications since 2023; last updated 2025-03-15)
Altmetric Attention Score: 270
Aerosolized Pulmonary Delivery of mRNA Constructs Attenuates Severity of Escherichia coli Pneumonia in the Rat
Nucleic Acid Therapeutics 2023-04-05
Altmetric Attention Score: 69
Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide Drug for 3849 + 10 kb C- > T Cystic Fibrosis Patients
Nucleic Acid Therapeutics 2023-09-02
Altmetric Attention Score: 59
Addressing the Challenges of Treating Patients with Heterozygous Gain of Function Mutations
Nucleic Acid Therapeutics 2024-09-25
Altmetric Attention Score: 53
Bioanalytical Assays for Oligonucleotide Therapeutics: Adding Antibody-Based Immunoassays to the Toolbox as an Orthogonal Approach to LC-MS/
Nucleic Acid Therapeutics 2025-02-25
Altmetric Attention Score: 45
Characterization of the TLR9-Activating Potential of LNA-Modified Antisense Oligonucleotides
Nucleic Acid Therapeutics 2024-07-19
Ad
5.0663590431213